Fourth, Stefan Scholtes (Cambridge) talked about market power in drug supply chains as studied in catalyst.nejm.org/doi/full/10...., ending with a call for other researchers to also investigate the long-run implications of creating non-for-profit drug manufacturers like Civica Rx
